XML 55 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net income $ 131,629 $ 393,158
Adjustments to reconcile net income to cash provided by operating activities:    
Settlement charge 495,000  
Settlement payments (493,775)  
Depreciation and amortization 312,632 288,470
Debt redemption and refinancing charges 48,072 97,548
Stock-based compensation expense 28,299 29,699
Tax benefits from stock award exercises 28,040 42,110
Excess tax benefits from stock award exercises (16,913) (30,238)
Deferred income taxes 4,418 13,826
Equity investment income, net 5,257 2,257
Other non-cash charges and loss on disposal of assets 24,718 22,861
Changes in operating assets and liabilities, other than from acquisitions and divestitures:    
Accounts receivable (142,950) (65,079)
Inventories (22,780) (10,731)
Other receivables and other current assets (50,362) (95,580)
Other long-term assets 378 2,158
Accounts payable 50,823 (46,022)
Accrued compensation and benefits (26,316) 19,912
Other current liabilities 177,733 31,970
Income taxes (109,460) 2,886
Other long-term liabilities (2,912) (17,707)
Net cash provided by operating activities 441,531 681,498
Cash flows from investing activities:    
Additions of property and equipment (290,873) (278,593)
Acquisitions (45,059) (98,442)
Proceeds from asset and business sales 3,415 215
Purchase of investments available for sale (3,872) (6,117)
Purchase of investments held-to-maturity (1,039,632) (121,333)
Proceeds from sale of investments available for sale 1,550 1,277
Proceeds from investments held-to-maturity 434,684 64,561
Purchase of intangible assets   (10)
Purchase of equity investments (7,550) (4,750)
Distributions received on equity investments   337
Net cash used in investing activities (947,337) (442,855)
Cash flows from financing activities:    
Borrowings 28,144,986 33,136,743
Payments on long-term debt and other financing costs (27,476,994) (32,788,307)
Deferred financing costs and debt redemption and refinancing costs (58,539) (106,937)
Purchase of treasury stock (84,113)  
Distributions to noncontrolling interests (79,040) (65,818)
Stock award exercises and other share issuances, net 4,680 7,274
Excess tax benefits from stock award exercises 16,913 30,238
Contributions from noncontrolling interests 18,040 28,265
Proceeds from sales of additional noncontrolling interests   933
Purchase of noncontrolling interests (10,840) (5,743)
Net cash provided by financing activities 475,093 236,648
Effect of exchange rate changes on cash and cash equivalents (793) (567)
Net (decrease) increase in cash and cash equivalents (31,506) 474,724
Cash and cash equivalents at beginning of the year 965,241 946,249
Cash and cash equivalents at end of the period $ 933,735 $ 1,420,973